Cutting Edge: Programmed Death-1/Programmed Death Ligand 1 Interaction Regulates the Induction and Maintenance of Invariant NKT Cell Anergy

被引:120
作者
Chang, Woo-Sung [1 ,2 ]
Kim, Ji-Yeon [1 ,2 ]
Kim, Yeon-Jeong [1 ,2 ]
Kim, Yun-Sun [1 ,2 ]
Lee, Jung-Mi [1 ,2 ]
Azuma, Miyuki [3 ]
Yagita, Hideo [4 ]
Kang, Chang-Yuil [1 ,2 ]
机构
[1] Seoul Natl Univ, Coll Pharm, Immunol Lab, Seoul 151742, South Korea
[2] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul 151742, South Korea
[3] Tokyo Med & Dent Univ, Dept Mol Immunol, Tokyo, Japan
[4] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan
关键词
D O I
10.4049/jimmunol.181.10.6707
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Invariant NKT (iNKT) cells are a distinct subset of T lymphocytes that recognize glycolipid Ags. Upon TCR stimulation, iNKT cells promptly secrete a wide range of cytokines and therefore have been investigated as a target for immunotherapy. However, after primary activation, iNKT cells become hyporesponsive toward their ligand (anergy). The further mechanism behind iNKT cell anergy is poorly understood. We found that a low level of programmed death-1 (PD-1) was constitutively expressed on iNKT cells and that PD-1 expression was increased after stimulation and lasted at least 2 mo. Moreover, not only did blocking of the PD-1/PD ligand 1 (PD-L1) pathway prevent the induction of anergy in iNKT cells, but anergic NKT cells also recovered responsiveness and these "rescued" cells efficiently mediated antitumor immunity. Our findings suggest that the PD-1/PD-L1 interaction is essential for the induction and maintenance of iNKT cell anergy. The Journal of Immunology, 2008,181: 6707-6710.
引用
收藏
页码:6707 / 6710
页数:4
相关论文
共 28 条
[1]   Restoring function in exhausted CD8 T cells during chronic viral infection [J].
Barber, DL ;
Wherry, EJ ;
Masopust, D ;
Zhu, BG ;
Allison, JP ;
Sharpe, AH ;
Freeman, GJ ;
Ahmed, R .
NATURE, 2006, 439 (7077) :682-687
[2]   The biology of NKT cells [J].
Bendelac, Albert ;
Savage, Paul B. ;
Teyton, Luc .
ANNUAL REVIEW OF IMMUNOLOGY, 2007, 25 :297-336
[3]   A critical role of costimulation during intrathymic development of invariant NK T cells [J].
Chung, Yeonseok ;
Nurieva, Roza ;
Esashi, Eiji ;
Wang, Yi-Hong ;
Zhou, Dapeng ;
Gapin, Laurent ;
Dong, Chen .
JOURNAL OF IMMUNOLOGY, 2008, 180 (04) :2276-2283
[4]  
Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730
[5]   Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway [J].
Fife, Brian T. ;
Guleria, Indira ;
Bupp, Melanie Gubbels ;
Eagar, Todd N. ;
Tang, Qizhi ;
Bour-Jordan, Helene ;
Yagita, Hideo ;
Azuma, Miyuki ;
Sayegh, Mohamed H. ;
Bluestone, Jeffrey A. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (12) :2737-2747
[6]   Prolonged IFN-γ-producing NKT response induced with α-galactosylceramide-loaded DCs [J].
Fujii, S ;
Shimizu, K ;
Kronenberg, M ;
Steinman, RM .
NATURE IMMUNOLOGY, 2002, 3 (09) :867-+
[7]   Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection [J].
Ha, Sang-Jun ;
Mueller, Scott N. ;
Wherry, E. John ;
Barber, Daniel L. ;
Aubert, Rachael D. ;
Sharpe, Arlene H. ;
Freeman, Gordon J. ;
Ahmed, Rafi .
JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (03) :543-555
[8]  
Hayakawa Y, 2001, EUR J IMMUNOL, V31, P1720, DOI 10.1002/1521-4141(200106)31:6<1720::AID-IMMU1720>3.0.CO
[9]  
2-U
[10]   Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade [J].
Iwai, Y ;
Ishida, M ;
Tanaka, Y ;
Okazaki, T ;
Honjo, T ;
Minato, N .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (19) :12293-12297